询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
4-Amino-2-piperidinone | CAS:5513-66-6
4-Amino-2-piperidinone
  • 名称:4-氨基-2-哌啶酮 | 4-Amino-2-piperidinone
  • CAS号:5513-66-6
  • 别名:
  • 分子式:C5H10N2O
  • 分子量:114.15
  • EINESC号:

产品描述

物理化学性质

没有数据没有数据

安全数据

没有数据没有数据

SDS

来源 SDS样本
Matrix 浏览或下载
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing.Tobias Killian et al.Scientific reports, 7(1), 15480-15480 (2017-11-15) Control of the Restriction Point by Rb and p21.Justin Moser et al.Proceedings of the National Academy of Sciences of the United States of America, 115(35), E8219-E8227 (2018-08-17) Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.Takeshi Maruyama et al.Nature biotechnology, 33(5), 538-542 (2015-03-24) Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma.Connor Rogerson et al.eLife, 9 (2020-09-04) Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases.Diane Yang et al.Scientific reports, 6, 21264-21264 (2016-02-19) Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing.Killian T, et al. Scientific Reports, 7(1), 15480-15480 (2017) An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression.Mrinal Srivastava et al.Cell, 151(7), 1474-1487 (2012-12-25) Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing in rats by inhibiting NHEJ and using Cas9 protein.Yuanwu Ma et al.RNA biology, 13(7), 605-612 (2016-05-11)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交